Could stem cells offer a lifeline for End-Stage liver disease?
NCT ID NCT06167473
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested whether umbilical cord stem cells given through a vein could help people with end-stage liver disease. Twenty-two adults received different doses to see if it improved survival and liver function. The goal was to find a safer, more accessible alternative to liver transplants.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for END-STAGE LIVER DISEASES are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
General Hospital of Northern Theater Command
Shenyang, Liaoning, 110840, China